M. Michelle Berrey
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, HIV Research and Treatment, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Early establishment of a pool of latently infected, resting CD4 + T cells during primary HIV-1 infection(1998)832 cited
- → Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C(2013)754 cited
- → Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy(1999)408 cited
- → Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial(2010)336 cited
- → Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial(2013)328 cited
- → Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial(2013)296 cited
- → Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment(2001)121 cited
- → Treatment of Primary Human Immunodeficiency Virus Type 1 Infection with Potent Antiretroviral Therapy Reduces Frequency of Rapid Progression to AIDS(2001)113 cited
- → Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults(2005)111 cited
- → Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis(2023)107 cited